logo-large
  • Browse Categories

Publications by authors named "Bas Jm Peters"

Claim this Profile
T
The effectiveness of pembrolizumab maintenance with or without pemetrexed after induction treatment for advanced non-squamous Non-Small-Cell Lung cancer.
Bas Jm Peters, Esmée van Geffen, Doranne Hilarius, Stephan Böhringer, Juliëtte Zwaveling

Lung Cancer· August 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab Plus Chemotherapy Per PD-L1 Stratum In Patients With Metastatic Non-Small Cell Lung Cancer: Real-World Effectiveness Versus Trial Efficacy.
Marjon V Verschueren, Bas Jm Peters, Lourens T Bloem, Veerle R Kruik, Elien B Uitvlugt

Clin Lung Cancer· March 2024


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durvalumab after chemoradiotherapy in patients with stage III non-small-cell lung cancer: real-world outcomes versus clinical trial results.
Marjon V Verschueren, Talitha Dijs, Judith L Gulikers, Ard van Veelen, Sander Croes, Bas Jm Peters

Immunotherapy· August 2023


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomic insights into treatment and management of statin-induced myopathy.
Bas Jm Peters, Olaf H Klungel, Frank L Visseren, Anthonius de Boer, Anke-Hilse Maitland-van der Zee

Genome Med· December 2009


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: